Not Alone: Pancreatic Cancer Survivorship Luncheon

Attendees at Cancer Services' first Pancreatic Survivorship Luncheon.

 
Survivors, caregivers and supporters gathered at Cancer Services this past Monday for our first Pancreatic Cancer Survivorship Luncheon. Survival rates tend to be dramatically lower for pancreatic cancer than other cancers and because of these statistics, many survivors* can feel hopeless and isolated, even within the cancer community. The Survivorship Luncheon gave them the opportunity to speak with fellow pancreatic cancer survivors who can empathize and share information. Conversation ranged from comparing their experiences of being diagnosed, to coaching a caregiver on what her mother might be going through, to sharing diet tips. For most though, simply meeting others with the disease was the reason for coming. Many of the attendees had never met a single other person with pancreatic cancer.
Paula Aliers, PANCAN facilitator of the monthly Pancreatic Survivor Network Meetings explains that, “It’s nice for patients to hear they’re not going crazy, that they’re not the only one and sometimes that’s hard because people don’t want to talk about pancreatic cancer – there’s a stigma there.” But there’s no stigma at Cancer Services. One of the attendees expressed in a thank-you note that, “I left the survivor party yesterday with such a sense of encouragement and finally felt like I had truly come to place where I could ‘take the mask off.’”

The Pancreatic Survivor Network meets at the General on Bluebonnet on the third Thursday of each month, from 6:30-8:30. For more information about Pancreatic Cancer, our support groups or anything else call Cancer Services at 225-927-2273 or visit our website.

Each month, Cancer Services will be hosting a different survivorship event to celebrate and honor survivors’ unique journeys. It’s no secret that some cancers get more attention than others. At Cancer Services we want to make sure all our clients feel supported in meaningful and relevant ways. Click here for a tentative schedule of the 2012 Survivorship Events.

*According to the National Cancer Survivors Day Foundation, a cancer survivor is anyone with a history of cancer, from the moment of diagnosis through their journey. Thus, Cancer Services refers to all clients as "survivors.” We are here for you and all 6,000 of our clients as you live with, through and beyond cancer.

Q&A: Pancreatic Cancer

Cancer Services will host a survivorship luncheon for pancreatic cancer survivors and their family members on Monday, January 30 from 11:30 a.m. – 1:00 p.m. For reservations, contact Natalie Depp at (225) 927-2273.

Every Sunday, Cancer Services publishes a Cancer Q&A in the Health Section of The Baton Rouge Advocate.

Q: What are some risks for pancreatic cancer?

A: According to the National Cancer Institute (NCI), it is not known what causes pancreatic cancer. However, studies have shown that if one or more of the following applies, you have a greater risk of developing pancreatic cancer. If you:

• are over 60 years old;
• smoke (smokers have 3 times the risk);
• have diabetes;
• are male;
• are African-American;
• have had a mother, father, sister, or brother with pancreatic cancer;
• have a family history of colon or ovarian cancer;
• have chronic pancreatitis.

However, there are instances where people with none of these risk factors get pancreatic cancer and people who have some of these risk factors may not get pancreatic cancer. It is important to assess your risk with your doctor.

For more information about pancreatic cancer, contact Courtney Britton, librarian at Cancer Services of Greater Baton Rouge at (225) 927-2273 or visit the Resource Center at 550 Lobdell Avenue. Also check out the PANCAN website for more information.

from the BBC News:

Cancer threat for young tanners
"More young people are being diagnosed with skin cancer, a consultant dermatologist has claimed."


from Michigan State University:

MSU research strengthens link between smoking, pancreatic cancer
"Researchers at Michigan State University have added yet another piece to the puzzle that links cigarette smoking with cancer of the pancreas, one of the deadliest forms of cancer."


from the American Cancer Society:

Federal Panel: Don't Use Pain Relievers to Guard Against Colon Cancer
"Not enough scientific evidence exists to support using aspirin and other pain relievers to prevent colorectal cancer, according to a federal task force. Taking such medications in high doses (300 milligrams and higher) on a regular basis would do more harm than good, they found, by increasing a person's risk for stroke, internal bleeding, and kidney failure."

Study: CT Scans Still Not Advised for Lung Cancer Screening
"The use of computed tomography (CT) scans to screen current or former smokers for lung cancer is still too experimental to recommend for widespread medical use, according to results from a new study. "


from the National Cancer Institute:

Researchers Discover New Biomarkers for Liver Cancer
"Researchers have found that a unique pattern of activity in cells surrounding a liver tumor can accurately predict whether the cancer will spread to other parts of the liver or to other parts of the body."

Cancer News


From the American Cancer Society:

Nutrition and Physical Activity Guidelines for Cancer Prevention: Summary
"This document is a condensed version of the article describing the American Cancer Society (ACS) Nutrition and Physical Activity Guidelines, which are updated every 5 years. The guidelines were developed by the American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee and approved by the American Cancer Society National Board of Directors on May 19, 2006. The full article, written for heath care professionals, is published in the September/October 2006 issue of CA: A Cancer Journal for Clinicians, and is available for free online at: http://caonline.amcancersoc.org/content/vol56/issue5/ "

Symptom Screening Advances Early Ovarian Cancer Detection
"Physicians generally consider ovarian cancer to be a “silent killer"...There is no effective screening test to detect early stage disease in the general population or even high-risk groups.
Recent evidence suggests that early-stage symptoms may be recognizable and could be used to develop a symptom index for early disease."


From MD Anderson:

Decline in Breast Cancer Cases Likely Linked to Reduced Use of Hormone Replacement
"But the researchers stress that because the analysis is based solely on population statistics, they cannot know for certain the reasons why incidence declined. "We have to sound a cautionary note because epidemiology can never prove causation," he says. They considered whether other effects may be involved (such as decreased use of screening mammography and changes in the use of anti-inflammatory agents, SERMs or statins) but only the potential impact of HRT was strong enough to explain the effect."

Allergy Drug Slows Pancreatic Tumor Growth in Preclinical Studies
"An anti-allergy drug in use for more than 40 years significantly reduced tumor growth in animal models of human pancreatic cancer and also increased the effectiveness of standard chemotherapy, say researchers at The University of Texas M. D. Anderson Cancer Center.
In the Dec. 20 issue of the Journal of the National Cancer Institute, the investigators report that combining the drug, cromolyn, with chemotherapy was nearly three times better at retarding growth of pancreatic tumors in mice compared to the chemotherapy agent gemcitabine alone.
The finding may lead to a treatment advance for patients with pancreatic cancer, believed to be the most lethal of all cancers. More than 95% of patients diagnosed with the disease die from it, and half of those deaths occur in the first six months after diagnosis."

Study Finds Lapatinib Shows Promise as Therapy for Inflammatory Breast Cancer: First multi-center clinical trial conducted for women with this rare disease
"In the first multi-center and international clinical trial conducted to better understand the complexities of a rare, aggressive and often lethal form of breast cancer, researchers have discovered that the experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer (IBC)."


From MacMillan Cancer Support:

Thousands of cancer patients lose their homes
Even though this survey was done in the UK, I think it's an important issue.
"New research out today shows one in seventeen (6%) people lose their home after being diagnosed with cancer and one in six (18%) have difficulties in keeping up with their mortgage or rental payments, according to Macmillan Cancer Support."


From UNC Chapel Hill Medical School:

Drug combination slows progression of treatment-resistant bone marrow cancer
"Combining a newly formulated drug with one that is already a standard treatment slows the progression of multiple myeloma, an advanced cancer of the bone marrow cells, according to a clinical trial led by a University of North Carolina at Chapel Hill School of Medicine researcher. "


From Google:

Cancer was the #3 Top Search of 2006 in Google News, right under Paris Hilton and Orlando Bloom.


Cancer-related Websites:

I'm Too Young for This
Website for cancer survivors.